Enanta Pharma Unveils Zelicapavir And EDP-323, Data For RSV
20 Oct 2025 //
BUSINESSWIRE
Enanta To Present Zelicapavir, EDP-323 RSV Data At IDWeek 2025
07 Oct 2025 //
PHARMIWEB
Enanta To Share Ph 2b Zelicapavir Results In RSV High-Risk Adults
26 Sep 2025 //
BUSINESSWIRE
Enanta Pharmaceuticals to Present Zelicapavir Data at ESPID
22 May 2025 //
BUSINESSWIRE
 
			 
								

 Market Place
 Market Place Sourcing Support
 Sourcing Support
